Advances in the Diagnosis, Pathogenesis, and Management of Fibromyalgia Syndrome PsychCast™

The Significance, Assessment, and Management of Nonrestorative Sleep in Fibromyalgia Syndrome (31:33 Minutes)

Author: Harvey Moldofsky, MD, Diploma in Psychiatry, FRCPC, FAPA

This is a 30 minute PsychCast™ podcast with an Internet component.

This CME Expert Review PsychCast™ is jointly sponsored by the Mount Sinai School of Medicine and MBL Communications.

Release Date: May 2008
Termination Date: May 31, 2010

Funding for this activity has been provided through an educational grant from Eli Lilly and Company and Pfizer Inc.

Faculty Affiliations and Disclosures:

Dr. Moldofsky is professor emeritus of the Faculty of Medicine at the University of Toronto and president of the Sleep Disorders Clinic of the Centre for Sleep and Chronobiology in Toronto, Ontario, Canada. Dr. Moldofsky is a consultant to, is on the advisory boards of, and receives research support from Eli Lilly, Jazz, Pfizer, and Pierre Fabre. This article references unlabeled or unapproved uses of duloxetine, milnacipran, pregabalin, and sodium oxybate.

Learning Objectives

• Explain the relationship between nonrestorative sleep and the often perplexing features of fibromyalgia syndrome, such as myalgia and tender points.
• Identify some methods of assessing nonrestorative sleep in fibromyalgia syndrome.

Target Audience: This activity is designed to meet the educational needs of psychiatrists.

Peer Reviewers:

Eric Hollander, MD, does not have an affiliation with or financial interest in any organization that might pose a conflict of interest. This activity has been peer-reviewed and approved by Eric Hollander, MD, Professor of Psychiatry and Chair at Mount Sinai School of Medicine. Review Date: February 15, 2008

Accreditation Statement: This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Mount Sinai School of Medicine and MBL Communications, Inc. The Mount Sinai School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: The Mount Sinai School of Medicine designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosure Policy Statement: It is the policy of Mount Sinai School of Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Disclaimer: These are the opinions of the authors not of the sponsors or supporters. For more information, contact MBL Communications at cme@mblcommunications.com.

Minimum Hardware/Software Requirements

Macintosh: PowerPC processor, Mac OS 8.6, 9.0.4, 9.1, or Mac OS X, 64MB of RAM, 24MB of available hard-disk space, and Safari 1.x or 2.x.
Windows PC: Intel Pentium processor, Microsoft Windows 95 OSR 2.0, Windows 98 and 98 SE, Windows Millennium Edition, Windows NT 4.0 with Service Pack 5, Windows 2000, or Windows XP, 64MB of RAM, 24MB of available hard-disk space, and Internet Explorer 6.x and newer or Firefox 1.x and newer.

This CME Activity and Posttest information file is a PDF (Portable Document Format) document. To view this file, you will need Adobe Acrobat Reader, which is available free at www.adobe.com. Follow the instructions on that page to download and install the software.